Sun Pharma rises after Q2 PAT jumps 11% YoY to Rs 2,262 cr

Sun Pharmaceutical Industries gained 1.87% to Rs 1,034.90 after the pharma major's consolidated net profit rose 10.51% to Rs 2,262.22 crore on 13.11% increase in revenue from operations to Rs 10,809.19 crore in Q2 FY23 over Q2 FY22.